Controlling sources of preanalytical variability in doping samples: Challenges and solutions

Bioanalysis

Volumn 5, Issue 12, 2013, Pages 1571-1582

  Lippi, Giuseppe ^a   Mattiuzzi, Camilla ^b   Banfi, Giuseppe ^c  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b Servizio Governance Clinica   (Italy)

^c IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; HEMOGLOBIN;

ATHLETE; BLOOD ANALYSIS; BLOOD SAMPLING; CREATININE BLOOD LEVEL; DOPING; EXERCISE; HEMATOCRIT; HEMOLYSIS; HUMAN; LABORATORY TEST; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; PRESERVATION AND STORAGE; REFERENCE VALUE; RETICULOCYTE COUNT; REVIEW; STANDARDIZATION; URINALYSIS; VENOUS STASIS;

DOPING IN SPORTS; HEMOGLOBINS; HEMOLYSIS; HUMANS; SPECIMEN HANDLING; TEMPERATURE;

EID: 84879635879     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.13.110     Document Type: Review

References (68)

1. Lippi G, Franchini M, Guidi GC. Doping in competition or doping in sport? Br. Med. Bull. 86, 95-107 (2008).
2. Lippi G, Sanchis-Gomar F, Banfi G. Anti-'negative-doping' testing: a new perspective in anti-doping research? Eur. J. Appl. Physiol. 112, 2383-2384 (2012).
3. Lippi G, Guidi GC, Mattiuzzi C, Plebani M. Preanalytical variability: the dark side of the moon in laboratory testing. Clin. Chem. Lab. Med. 44, 358-365 (2006).
4. Lippi G, Banfi G, Maffulli N. Preanalytical variability: the dark side of the moon in blood doping screening. Eur. J. Appl. Physiol.109, 1003-1005 (2010).
5. Lippi G, Montagnana M, Salvagno GL, Franchini M, Guidi GC. Glycaemic control in athletes. Int. J. Sports Med. 29, 7-10 (2008).
6. Lippi G, Schena F, Salvagno GL, Montagnana M, Ballestrieri F, Guidi GC. Comparison of the lipid profile and lipoprotein(a) between sedentary and highly trained subjects. Clin. Chem. Lab. Med. 44, 322-326 (2006).
7. Lippi G, Banfi G, Luca Salvagno G, Montagnana M, Franchini M, Cesare Guidi G. Comparison of creatinine-based estimations of glomerular filtration rate in endurance athletes at rest. Clin. Chem. Lab. Med. 46, 235-239 (2008).
8. Lippi G, Plebani M. Athlete's biological passport: to test or not to test? Clin. Chem. Lab. Med. 49, 1393-1395 (2011).
9. Lippi G, Schena F, Montagnana M, Salvagno GL, Banfi G, Guidi GC. Significant variation of traditional markers of liver injury after a half-marathon run. Eur. J. Intern. Med. 22, e36-e38 (2011).
10. Lippi G, Schena F, Salvagno GL et al. Acute variation of estimated glomerular filtration rate following a half-marathon run. Int. J. Sports Med. 29, 948-951 (2008).
11. Lippi G, Schena F, Montagnana M, Salvagno GL, Banfi G, Guidi GC. Acute variation of osteocalcin and parathyroid hormone in athletes after running a half-marathon. Clin. Chem. 54, 1093-1095 (2008).
12. Lippi G, Banfi G, Montagnana M, Salvagno GL, Schena F, Guidi GC. Acute variation of leucocytes counts following a half-marathon run. Int. J. Lab. Hematol. 32, 117-121 (2010).
13. Banfi G, Lundby C, Robach P, Lippi G. Seasonal variations of haematological parameters in athletes. Eur. J. Appl. Physiol. 111, 9-16 (2011).
14. Banfi G, Del Fabbro M, Lippi G. Creatinine values during a competitive season in elite athletes involved in different sport disciplines. J. Sports Med. Phys. Fitness 48, 479-482 (2008).
15. Banfi G, Del Fabbro M, Lippi G. Relation between serum creatinine and body mass index in elite athletes of different sport disciplines. Br. J. Sports Med. 40, 675-678 (2006).
16. Banfi G, Lombardi G, Colombini A, Lippi G. Bone metabolism markers in sports medicine. Sports Med. 40, 697-714 (2010).
17. Ahlgrim C, Pottgiesser T, Robinson N, Sottas PE, Ruecker G, Schumacher YO. Are 10 min of seating enough to guarantee stable haemoglobin and haematocrit readings for the athlete's biological passport? Int. J. Lab. Hematol. 32, 506-511 (2010).
18. Lippi G, Lima-Oliveira G, Salvagno GL et al. Influence of a light meal on routine haematological tests. Blood Transfus. 8, 94-99 (2010).
19. Lima-Oliveira G, Salvagno GL, Lippi G et al. Influence of a regular, standardized meal on clinical chemistry analytes. Ann. Lab. Med. 32, 250-256 (2012).
20. Schumacher YO, Klodt F, Nonis D et al. The impact of long-haul air travel on variables of the athlete's biological passport. Int. J. Lab. Hematol. doi:10.1111/j.1751-553X.2012. 01450.x (2012) (Epub ahead of print).
21. Lippi G, Becan-McBride K, Behúlová D et al. Preanalytical quality improvement: in quality we trust. Clin. Chem. Lab. Med. 51, 229-241 (2013).
22. Lippi G, Sonntag O, Plebani M. Appropriate labelling of blood collection tubes: a step ahead towards patient's safety. Clin. Chem. Lab. Med. 49, 1921-1923 (2011).
23. Lippi G, Plebani M. Primary blood tubes mixing: time for updated recommendations. Clin. Chem. Lab. Med. 50, 599-600 (2012).
24. Banfi G, Salvagno GL, Lippi G. The role of ethylenediamine tetraacetic acid (EDTA) as in vitro anticoagulant for diagnostic purposes. Clin. Chem. Lab. Med. 45, 565-576 (2007).
25. Bull BS, Fujimoto K, Houwen B et al. ICSH Expert Panel on Cytometry. International Council for Standardization in Haematology
26. (ICSH) recommendations for 'surrogate reference' method for the packed cell volume. Lab. Hematol. 9, 1-9 (2003).
27. Lippi G, Mattiuzzi C, Guidi GC. Laboratory quality improvement by implementation of phlebotomy guidelines. MLO Med. Lab. Obs. 38, 6-7 (2006).
28. Lippi G, Salvagno GL, Montagnana M, Franchini M, Guidi GC. Phlebotomy issues and quality improvement in results of laboratory testing. Clin. Lab. 52, 217-230 (2006).
29. Lippi G, Salvagno GL, Montagnana M, Brocco G, Guidi GC. Influence of short-term venous stasis on clinical chemistry testing. Clin. Chem. Lab. Med. 43, 869-875 (2005).
30. Lippi G, Salvagno GL, Montagnana M, Guidi GC. Short-term venous stasis influences routine coagulation testing. Blood Coagul. Fibrinolysis 16, 453-458 (2005).
31. Lippi G, Salvagno GL, Montagnana M, Franchini M, Guidi GC. Venous stasis and routine hematologic testing. Clin. Lab. Haematol. 28, 332-337 (2006).
32. Lippi G, Salvagno GL, Solero GP, Guidi GC. The influence of the tourniquet time on hematological testing for antidoping purposes. Int. J. Sports Med. 27, 359-362 (2006).
33. Banfi G. Limits and pitfalls of Athlete's Biological Passport. Clin. Chem. Lab. Med. 49, 1417-1421 (2011).
34. Lima-Oliveira G, Lippi G, Salvagno GL et al. Transillumination: a new tool to eliminate the impact of venous stasis during the procedure for the collection of diagnostic blood specimens for routine haematological testing. Int. J. Lab. Hematol. 33, 457-462 (2011).
35. Lippi G, Blanckaert N, Bonini P et al. Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories. Clin. Chem. Lab. Med. 46, 764-772 (2008).
36. Lippi G, Plebani M, Di Somma S, Cervellin G. Hemolyzed specimens: a major challenge for emergency departments and clinical laboratories. Crit. Rev. Clin. Lab. Sci. 48, 143-153 (2011).
37. Lippi G, Avanzini P, Pavesi F et al. Studies on in vitro hemolysis and utility of corrective formulas for reporting results on hemolyzed specimens. Biochem. Med. (Zagreb) 21, 297-305 (2011).
38. Lippi G, Banfi G, Buttarello M et al. Recommendations for detection and management of unsuitable samples in clinical laboratories. Clin. Chem. Lab. Med. 45, 728-736 (2007).
39. Plebani M, Lippi G. Hemolysis index: quality indicator or criterion for sample rejection? Clin. Chem. Lab. Med. 47, 899-902 (2009).
40. Lippi G, Pavesi F, Cattabiani C, Avanzini P, Pipitone S. Influence of in vitro hemolysis on nucleated red blood cells and reticulocyte counts. Int. J. Lab. Hematol. 35(2), 225-228. (2012).
41. Lippi G, Musa R, Avanzini P, Aloe R, Pipitone S, Sandei F. Influence of in vitro hemolysis on hematological testing on Advia 2120. Int. J. Lab. Hematol. 34, 179-184 (2012).
42. Lippi G, Pipitone S, Gennari D, Franchini M. Identification of spurious hemolysis in anticoagulated blood with Sysmex XE-2100 and Siemens Advia 2120. Clin. Lab. 58, 801-804 (2012).
43. Lippi G, Franchini M. Lipaemic donations: truth and consequences. Transfus. Apher. Sci. doi: 10.1016/j.transci.2012.10.001 (2012) (Epub ahead of print).
44. Lippi G, Romero A, Cervellin G, Mercadanti M. Unusual false-positive case of urinary screening for buprenorphine. J. Clin. Lab. Anal. 25, 244-245 (2011).
45. Ventura R, Segura J. Masking and manipulation. Handb. Exp. Pharmacol. 195, 327-354 (2010).
46. Sanchis-Gomar F, Martinez-Bello VE, Nascimento AL et al. Desmopresssin and hemodilution: implications in doping. Int. J. Sports Med. 31, 5-9 (2010).
47. Thevis M, Maurer J, Kohler M, Geyer H, Schänzer W. Proteases in doping control analysis. Int. J. Sports Med. 28, 545-549 (2007).
48. Sanchis-Gomar F, Martinez-Bello VE, Nascimento AL, Gomez-Cabrera MC, Viña J. Alternate methods to prevent protease use as a masking agent in sport. J. Sci. Med. Sport 13, 473-474 (2010).
49. Tsivou M, Georgakopoulos DG, Dimopoulou HA, Koupparis MA, Atta-Politou J, Georgakopoulos CG. Stabilization of human urine doping control samples: a current opinion. Anal. Bioanal. Chem. 401, 553-561 (2011).
50. Tsivou M, Livadara D, Georgakopoulos DG, Koupparis MA, Atta-Politou J, Georgakopoulos CG. Stabilization of human urine doping control samples: II. microbial degradation of steroids. Anal. Biochem. 388, 146-154 (2009).
51. Tsivou M, Livadara D, Georgakopoulos DG, Koupparis MA, Atta-Politou J, Georgakopoulos CG. Stabilization of human urine doping control samples. Anal. Biochem. 388, 179-191 (2009).
52. Lippi G, Lima-Oliveira G, Nazer SC et al. Suitability of a transport box for blood sample shipment over a long period. Clin. Biochem. 44, 1028-1029 (2011).
53. Sanchis-Gomar F, Martínez-Bello VE, Olaso-González G, Gómez-Cabrera MC, Viña J. Different types of storage devices for blood transportation in the anti-doping field. Clin. Biochem. 44, 1361 (2011).
54. Zaninotto M, Tasinato A, Padoan A et al. Effects of sample transportation on commonly requested laboratory tests. Clin. Chem. Lab. Med. 50, 1755-1760 (2012).
55. Lippi G, Chance JJ, Church S et al. Preanalytical quality improvement: from dream to reality. Clin. Chem. Lab. Med. 49, 1113-1126 (2011).
56. Lippi G, Salvagno GL, Solero GP, Franchini M, Guidi GC. Stability of blood cell counts, hematologic parameters and reticulocytes indexes on the Advia A120 hematologic analyzer. J. Lab. Clin. Med. 146, 333-340 (2005).
57. Lombardi G, Lanteri P, Colombini A, Lippi G, Banfi G. Stability of haematological parameters and its relevance on the athlete's biological passport model. Sports Med. 41, 1033-1042 (2011).
58. Ashenden M, Clarke A, Sharpe K, D'Onofrio G, Plowman J, Gore CJ. Stability of athlete passport parameters during extended storage. Int. J. Lab. Hematol. 35(2), 183-192 (2013).
59. Kouri T, Siloaho M, Pohjavaara S et al. Pre-analytical factors and measurement uncertainty. Scand. J. Clin. Lab. Invest. 65, 463-475 (2005).
60. Banfi G, Lombardi G, Colombini A, Lippi G. Analytical variability in sport hematology: its importance in an antidoping setting. Clin. Chem. Lab. Med. 49, 779-782 (2011).
61. Sanchis-Gomar F, Cortell-Ballester J, Pareja-Galeano H, Banfi G, Lippi G. Hemoglobin point-of-care testing: the HemoCue system. J. Lab. Autom. 18(3), 198-205 (2013).
62. Greene DN, Schmidt RL, Kamer SM, Grenache DG, Hoke C, Lorey TS. Limitations in qualitative point of care hCG tests for detecting early pregnancy. Clin. Chim. Acta 415, 317-321 (2013).
63. Atkinson KR, Lo KR, Payne SR, Mitchell JS, Ingram JR. Rapid saliva processing techniques for near real-time analysis of salivary steroids and protein. J. Clin. Lab. Anal. 22, 395-402 (2008).
64. Sottas PE, Saudan C, Saugy M. Doping: a paradigm shift has taken place in testing. Nature 455, 166 (2008).
65. World Anti-Doping Agency. 2013 prohibited list.http://list.wada-ama.org
66. World Anti-Doping Agency. Athlete biological passport. Operating guidelines. April 2012. Version 3.1.www.wada-ama.org.
67. World Anti-Doping agency. Guidelines for blood sample collection. August 2011. Version 2.3. www.wada-ama.org
68. International Standards Organisation ISO 6710. Single-use containers for venous blood specimen collection.www.iso.org/iso/home.html